Lightcalls.com
 

A friend and partner of choline, wo...

A friend and partner of choline, working to boost learning and memory.

There are quite a number of complements available over the counter that have an influence in succession the brain (our most tangled organ) and the mind (our temper memory, ability to learn, and other mental functions). It is frequently difficult for the consumer to know which of these supplys to choose. In the following month I will discuss many of these continuations so that you have a better idea of each one's benefits and shortcomings. This month let's take a closer turn the thoughts at DMAE, and what benefits it may provide for you.

Known chemically as dimethyl-aminoethanol, DMAE is structurally to a high degree similar to choline, a nutrient necessary to make the brain chemical acetylcholine. Choline, as a certain quantity of of you may recall from last month's "Brain Boosters" line is involved in the proces of learning and memory.

Studies with DMAE advance back to the 1950s. Let's review a few:



Autism. In 1988 an investigator at the Institute for Child Behavior in San Diego mannersed a survey of parents of autistic children (Rimland, 1988) Approximately 4000 questionnaires were complet through participating parents, who provided ratings forward a variety of treatments and interventions. Among the nutritional treatments, the use of high-dosage vitamin B-6 and magnesium received the highest ratings, with eight parents reporting behavioral improvement to each one reporting behavioral worsening. DMAE was the nearest most highly rated supplement, with sum of two units parents reporting improvement to each undivided reporting worsening.

Memory deficits. Twenty-one patients showing memory deficits participated in neuropsychological testing, before and after treatment with DMAE (Caffarra, 1980) No significant tenor was found. DMAE at a dose of 900 mg a day for 21 days had no general intent on learning a list of words in normal somewhat old persons or those with no other than minimal cognitive decline (Marsh, 1979)

Dementia. DMAE was given plainly for four weeks to 14 outpatients to determine the safety of the unsalable article and whether or not it improves mental function (Ferris, 1977) The dosage was gradually increased to 600 mg three times daily during the first pair weeks, with no adverse general intents Ten patients improved and four were unchanged. The patients onward DMAE had reduced depression, irritability, and anxiety, as well as increased motivation. However, there were no apparent changes in memory. The researchers say, "The deductions thus suggest that, although DMAE may not improve memory, it may bring forth positive behavioral changes in near patients."

As you can behold the results of studies with DMAE have been inconsistent, although favorable, in the main.

Availability. DMAE is usually sold as DMAE bitartrate. A 350-mg capsule of DMAE bitartrate yields 130 mg of actual DMAE. It is also available in liquid form. a liquid products contain 35 mg of DMAE through drop.

Side efficiencys High dosages can induce irritability, anxiety, headaches, and stiffness in the jaw, neck and shoulder.

The experience of a link of DMAE-takers. Audrey, a 32-year-old patient says, "DMAE stimulates my thinking and helps me become more motivated. I take DMAE during days when I ne to be more focused at work and thorough a project that I've been postponing."

principally patients usually report similar drifts particularly the ability to focus better. However, higher dosages can be counterproductive. Jennifer, a 35-year-old computer analyst, says, "I have taken DMAE upon numerous occasions over the last not many months. Small doses are fine, and help me become more alert and focused, however my problems come with dosages exceeding 350 mg I realize anxious and irritable."

My personal experience. Within a not many hours of taking DMAE, I notice an increase in alertness and slight vein and visual enhancement. I also become more motivated to work forward projects, and seem to work more efficiently. onward higher dosages, I have experienced slight neck stiffness.

Recommendations and cautions. DMAE can potentially be helpful in the somewhat old who have mental decline through improving alertness and focus. However, the long-term effectiveness of this nutrient is publicly not known. DMAE is best reserv for occasional use upon days when we have a special ne to be more focused and alert.

REFERENCES

Caffarra, P et al. "The consequence of Deanol on amnesic disorders. A preliminary trial (author's transl)," Ateneo Parmense [Acta Biomed.] 51(4):383-9 1980

Ferris, SH et al. "Senile dementia: treatment with deanol," J Am. Geriatr. Soc 25(6):241-4 1977

Marsh, GR and M Linnoila. "The efficiencys of deanol on cognitive performance and electrophysiology in somewhat old humans," Psychopharmacology (Berl) 66(1):99-104, 1979

Rimland, B "Controversies in the treatment of autistic children: vitamin and mix with drugs therapy," J. Child. Neurol. 3 Suppl:S68-72 1988

COPYRIGHT 1999 PRIMEDIA Intertec, a PRIMEDIA Company. All Rights Reserved

COPYRIGHT 2000 Gale Group



Other Articles
 -Morphotek will collaborat...
 -Eksigent Technologies nam...
 -The benefits of outsourci...
 -Sartorius Corporation ...
 -In our previous column, w...
 -Efoora appointed Michael ...
 -Affymax appointed Anne-Ma...
 -Traditionally, continuous...
 -New Brunswick Scientific ...
 -The German-American firm ...
 -Don G. Burstyn, formerly ...
 -American patients are mor...
 -Summary Prior to va...
 -BioPharm Editorial Adviso...
 -Australia agreed to spend...
 -The Biotechnology Industr...
 -Ambion, The RNA Company i...
 -Therapies based on living...
 -A recent survey found tha...
 -ViroLogic will acquire Ac...
 -Cardinal Health named Joh...
 -One of the greatest chall...
 -As the president of a sma...
 -Sweden-based Biovitrum wi...
 -Nanogen appointed David L...
 -The Experion Process Know...
 -Although biomedical resea...
 -The Supreme Court of Cana...
 -Netherlands-based DSM Bio...
 -David A. Smoller joined S...
 -A few months ago, I wrote...
 -Panacos Pharmaceuticals w...
 -Karen K. Vaccaro will res...
 -Acceleron Pharma appointe...
 -Two quarterly meetings of...
 -Illinois-based Abbot Labo...
 -FKI Logistics announced t...
 -The following corrections...
 -It its widest definition,...
 -UK-based Xcellsyz will li...
 -Andrew P. Aromando joined...
 -Invitrogen's comprehensiv...
 -Last month, we described ...
 -The Swiss life sciences c...
 -Protein Design Labs (PDL)...
 -Model It HNMR, the newest...
 -Tech transfer, like chang...
 -QLT and Atrix Laboratorie...
 -Dendreon announced Christ...
 -Baxter Pharmaceutical Sol...
 -The biopharmaceutical ind...
 -GlaxoSmithKline announced...
 -Montreal-based Caprion Ph...
 -Xenova Group recently ann...
 -Cole-Parmer's new 192-pag...
 -Over the last decade ther...
 -Benchmark your facility p...
 -As biotechnology organiza...
 -Frederick D. Sancillo, fo...
 -Insmed acquired a recombi...
 -Baxter Pharmaceutical Sol...
 -Model It HNMR, the newest...
 -DA's regulation 21 CFR Pa...
 -Robert P. Ryan joined Ath...
 -A new report from Busines...
 -Biotest offers a complete...
 -Swagelok offers a brochur...
 -Partnering is a global ph...
 -Human Genome Sciences CEO...
 -Shorten the process devel...
 -The licensure of biotechn...
 -Rodger Currie joined Amge...
 -The GEA Filtration Model ...
 -A multi-channel chemistry...
 -From June 6-9, San Franci...
 -Skanska USA Building Inc....
 -New Brunswick Scientific'...
 -AVI BioPharma appointed P...
 -Ambion, The RNA Company, ...
 -"If you want to be a...
 -Xcellerex appointed Susan...
 -Researchers identified th...
 -Cool Spring Business Park...
 -In October 2003, Shenzhen...
 -Laureate Pharma appointed...
 -After a 6-5 vote by Calif...
 -QSourcing, a service of Q...
 -The recent discovery of &...
 -Affymax added Douglas L. ...
 -USDA recently approved tw...
 -BioPharm International is...
 -Serologicals has released...
 -This document by Shenzhen...
 -Robert Bronstein joined A...
 -Gloucester Gains Fujisawa...
 -With more than 30 years o...
 -Pall's SUPRAdisc II depth...
 -In today's competitive ma...
 -Protein Design Labs repor...
 -Charles A. Rice will repl...
 -AstraZeneca's Faslodex (f...
.
© 2006 Lightcalls.com All rights reserved.